Product Advantages

(1) Outstanding Gene Panel Design: HapOnco^® StarPanel™ has an excellent gene panel design, covering approved targeted drugs and targeted therapy related genes, MSI/tTMB/bTMB and other immunotherapy related tests, chemotherapy/endocrine therapy related genes, hereditary tumor risk assessment, and viral typing tests, which can better meet the clinical testing needs.
(2) High-Depth Sequencing: With ultra-high-depth sequencing of ctDNA at 20,000X, HapOnco^® StarPanel™ is able to achieve a mutation LoD as low as 0.3% VAF, reducing the risk of false negatives and missed detection. This precise detection of genomic mutations assists in analyzing drug resistance mechanisms and dynamically monitoring disease progression.

Applicable Population

This product is well-suited for solid tumor patients in need of i) targeted therapy, immunotherapy, chemotherapy, endocrine therapy; ii) facing challenges such as treatment resistance, suboptimal responses, metastasis; iii) requiring treatment plan adjustments.